Illumina
ILMN
$122.87
Share price
-1.28%
Change (1 day)
-46.36%
Change (1 year)
Categories
Operating Margin for Illumina (ILMN)
Operating Margin as of April 2024 (TTM): -94.58%
According to Illumina's latest financial reports and stock price the company's current Operating Margin is -94.58%. At the end of 2022 the company had an Operating Margin of -94.59%.
Operating Margin history for Illumina from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -94.59% | -584.29% |
| 2021 | 19.53% | -26.09% |
| 2020 | 26.43% | -16.25% |
| 2019 | 31.56% | 17.64% |
| 2018 | 26.82% | -29.23% |
| 2017 | 37.90% | 61.98% |
| 2016 | 23.40% | -10.93% |
| 2015 | 26.27% | 8.96% |
| 2014 | 24.11% | 115.07% |
| 2013 | 11.21% | -42.16% |
| 2012 | 19.38% | 53.77% |
| 2011 | 12.60% | -38.62% |
| 2010 | 20.54% | 19.9% |
| 2009 | 17.13% | 8% |
| 2008 | 15.86% | -120.14% |
| 2007 | -78.73% | -440.98% |
| 2006 | 23.09% | -400.53% |
| 2005 | -7.68% | -29.51% |
| 2004 | -10.90% | -88.52% |
| 2003 | -94.96% | -77.22% |
| 2002 | -416.88% | -65.82% |
| 2001 | -1,219.59% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -114.98% | 🇺🇸 USA |
 Agilent Technologies A | 23.28% | -124.61% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 11.10% | -111.74% | 🇺🇸 USA |
 Danaher DHR | 26.34% | -127.85% | 🇺🇸 USA |
 PerkinElmer
PKI | 14.13% | -114.94% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | 18.52% | -119.58% | 🇺🇸 USA |
 Pacific Biosciences
PACB | -218.42% | 130.94% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.